This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. Lyle Craker, Ph.D.,
In February 2021, a lawsuit was filed against the DEA for prohibiting access for others aside from the University of Mississippi to cultivate cannabis for research purposes. Lyle has been seeking authorization to become a federally licensed cannabis cultivator since 2001.
The Drug Enforcement Administration (DEA) seems happy to respond to public and private parties inquiring about the control status of various substances. DEA answers some of these inquiries more quickly than others, and the response letters are usually short and to the point. What are the legal ramifications of DEA writing these things?”
The Drug Enforcement Administration (DEA) seems happy to respond to public and private parties inquiring about the control status of various substances. DEA answers some of these inquiries more quickly than others, and the response letters are usually short and to the point. What are the legal ramifications of DEA writing these things?”
A group of activists dressed in ape suits danced around an eight-foot monolith that they erected outside of the Drug Enforcement Administration (DEA) headquarters on Wednesday, calling on the agency to evolve its policies on marijuana and other controlled substances. It’s OK if you need to read that again. Read more at.
This stems from the fact that despite the ongoing legalization of both recreational and medical marijuana at the state level, cannabis is still classified as a Schedule I substance by the DEA, along with substances such as heroin, cocaine, opioids and methamphetamine.
Michael Mithoefer, a clinical psychiatry faculty member at the Medical University of South Carolina who has worked on MDMA trials since 2001, expressed frustration: “I expected a delay, but I didn’t expect this—this is extreme.”
31) The United States DEA has stated that small amounts of other cannabinoids will also occur in all cannabis extracts, even those that purport to be CBD only – unless synthesized de novo, CBD isolate will always contain small amounts of THC when extracted from a plant. 25, November/December 2001. 32: United States DEA.
Last week the Drug Enforcement Administration (DEA) issued a bad interim hemp rule. North Carolina attorney Rod Kight raised these concerns as well and he and I both spoke to Kyle Jaeger of Marijuana Moment about why we think are concerned about the DEA’s interim hemp rule. Weekly in a phone interview.
He opened the doors on April 4, 2001, and, remarkably, was never raided. The DEA was targeting those people who put their heads above the parapet. Now, that money is being made available for those that need it. Mr O’Brien also runs the longest running dispensary in the world: The Patients Care Collective in Berkely.
The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. 26, 2001 , 115 Stat. 26, 2001 , 115 Stat. 106–569, title VII , § ? 709(a), Dec. 3018 ; Pub.
In 2001 the “Hempcar” circled the North American continent powered by hemp oil. I feel that if it was taken off the list and proved to the DEA, FDA, or whoever else…that it isn’t a narcotic then we can get some headway on this wonderful, helpful plant.
The filing is backed by MAPS (Multidisciplinary Association for Psychedelic Studies) and calls on the DEA to answer a four-year-old filing requesting approval of his application to become a federally registered marijuana cultivator. Back in 2016, the DEA said they were starting the process of approving “additional marijuana cultivators.”
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content